Shen Changxian, Zhou Yonggang, Zhan Jun, Reske Sven N, Buck Andreas K
Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
J Cell Biochem. 2008 Dec 15;105(6):1327-41. doi: 10.1002/jcb.21937.
The maintenance and survival of each organism depends on its genome integrity. Alterations of essential genes, or aberrant chromosome number and structure lead to cell death. Paradoxically, cancer cells, especially in solid tumors, contain somatic gene mutations and are chromosome instability (CIN), suggesting a mechanism that cancer cells have acquired to suppress the lethal mutations and/or CIN. Herein we will discuss a tumor lethality suppression concept based on the studies of yeast genetic interactions and transgenic mice. During the early stages of the multistep process of tumorigenesis, incipient cancer cells probably have adopted genetic and epigenetic alterations to tolerate the lethal mutations of other genes that ensue, and to a larger extent CIN. In turn, CIN mediated massive gain and loss of genes provides a wider buffer for further genetic reshuffling, resulting in cancer cell heterogeneity, drug resistance and evasion of oncogene addiction, thus CIN may be both the effector and inducer of tumorigenesis. Accordingly, interfering with tumor lethality suppression could lead to cancer cell death or growth defects. Further validation of the tumor lethality suppression concept would help to elucidate the role of CIN in tumorigenesis, the relationship between CIN and somatic gene mutations, and would impact the design of anticancer drug development.
每个生物体的维持和生存取决于其基因组的完整性。必需基因的改变,或异常的染色体数目和结构会导致细胞死亡。矛盾的是,癌细胞,尤其是实体瘤中的癌细胞,含有体细胞基因突变且具有染色体不稳定性(CIN),这表明癌细胞已经获得了一种机制来抑制致死性突变和/或CIN。在此,我们将基于酵母遗传相互作用和转基因小鼠的研究来讨论一种肿瘤致死性抑制概念。在肿瘤发生的多步骤过程的早期阶段,初期癌细胞可能已经发生了遗传和表观遗传改变,以耐受随后出现的其他基因的致死性突变,并在更大程度上耐受CIN。反过来,CIN介导的大量基因得失为进一步的基因重排提供了更广泛的缓冲,导致癌细胞异质性、耐药性和对癌基因成瘾的逃避,因此CIN可能既是肿瘤发生的效应器又是诱导剂。相应地,干扰肿瘤致死性抑制可能导致癌细胞死亡或生长缺陷。肿瘤致死性抑制概念的进一步验证将有助于阐明CIN在肿瘤发生中的作用、CIN与体细胞基因突变之间的关系,并将影响抗癌药物开发的设计。